Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours
10.1038/bjc.2013.225
Saved in:
Main Authors: | Ling, W.H.Y., Soe, P.P., Pang, A.S.L., Lee, S.-C. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110746 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients
by: Lim, L.L., et al.
Published: (2016) -
Prophylactic lamivudine prevents hepatitis B reactivation in chemotherapy patients
by: Lim, L.L., et al.
Published: (2014) -
Chemotherapy regimen and incidence of malnutrition after chemotherapy in non-small cell lung cancer
by: Buntitabhon Sirichancheun, et al.
Published: (2019) -
Cancer informatics for the clinician: An interaction database for chemotherapy regimens and antiepileptic drugs
by: Yap, K.Y.-L., et al.
Published: (2014) -
Renal tumours: A common incidental finding
by: Esuvaranathan, K., et al.
Published: (2011)